Korsana Biosciences, Inc.

US$31.05As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KRSAHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (45.02%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.84
PE TTM —
TSR TTM 137.20%
Mkt cap US$1.414B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$33
6.67%
(96.17%)
Sell 1|4|4|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.39
0.43
0.42
0.46
25.91%
32.22%
19.11%
23.55%
Revenue$M
97.77
97.87
97.01
99.78
16.66%
10.69%
9.54%
6.74%
Peers (US$1.414B)
Cap (US$)
PE
1.389B
6.637x
Capital
TTM
5Y
10Y
Leveragex
0.199
0.210
0.180
EBIT/Intx
0.581
0.080
0.076
Own earn%
55.47
80.40
69.48
Sh yield%
32.84
15.62
19.48
Owners
Insiders/Inst%
5.30
54.59
Short interest%
2.34
SBC / revenue%
0.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
4–14
$1 testx
—
Incr. ROIC%
4